New Document top_band
 
Business Standard

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Read more on:    Drug | Lipitor | Atorvastatin | Dr Reddy's
Related News

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched Atorvastatin calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of Lipitor tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of Dr Reddy's ANDA for atorvastatin calcium tablets, a company statement said here.

The Lipitor brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr Reddy's Atorvastatin calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering Lipitor tablets. New York-based Pfizer had sued Dr Reddy's in 2009.

Read more on:   
|
|
|

Read More

Jaguar launches XKR special edition at Rs 1.27 cr

Tata Motors-owned Jaguar today said it has launched the XKR special edition luxury sedan in India, priced at Rs 1.27 crore (ex-showroom, Delhi).

Quick Links

Advertisement

Back to Top